姓名：刘福生 性别：男 职称：教授
招生类型：科学与专业学位(硕) 科学与专业学位(博)
招生专业：外科学（神外）(硕) 外科学（神外）(博)
研究方向：胶质瘤的基础和临床
电子信箱：liufushengs@hotmail.com
社会任职
1. 《中华诊断学电子杂志》 编委
2. 生物医学材料-北京实验室 专家委员会委员
3. 北京市卫生系统高层次卫生技术人才 神经外科学科带头人
4. 《中华脑科疾病与康复杂志（电子版）》审稿专家
5. 《中华临床医师杂志（电子版）》 特邀审稿专家
6. 《中华临床医师杂志（电子版）》 编委
7. 《药品评价》常务编委
个人简历
1. 200411- :北京市神经外科研究所脑肿瘤研究中心及首都医科大学附属北京天坛医院神外六病房 脑肿瘤研究中心主任；教授、主任医师、 研究员
2. 200205-200411:美国国立卫生研究院（National Institutes of Health,NIH) 博士后
3. 200107-200205:北京市神经外科研究所及首都医科大学附属北京天坛医院神外 副研究员
4. 199909-200107:首都医科大学临床医学博士后流动站 博士后
5. 199609-199907:山东医科大学神经外科博士学位研究生 获博士学位
6. 199307-199608:潍坊医学院附属医院神经外科 主治医师
7. 199009-199307:山东医科大学神经外科硕士学位研究生 获硕士学位
8. 198707-199009:潍坊市益都中心医院 住院医师
9. 198209-198707:潍坊医学院医疗系 学生，获学士学位
重要学术论文
1. Zhang Q, Wang Y, Liu F*.Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.Cell Signal.2023.103.110567.SCI
2. Wang P, Zhang J, Zhang Q, Liu F *.Mesenchymal stem cells loaded with Ad5-Ki67/IL-15 enhance oncolytic adenovirotherapy in experimental glioblastoma.Biomed Pharmacother.2023.157.114035.SCI
3. Liu SS, Li MX, Sun FQ, Zhang JW, Liu FS *.Enhancing the immune effect of oHSV-1 therapy through TLR3 signaling in uveal melanoma.J Cancer Res Clin.2023.149(2).901-912.SCI
4. Zhang JW, Wang JL, Li M, Su XD, Tian YF, Wang PW, Zhou XZ, Jin GS, Liu FS *.Oncolytic HSV-1 suppresses cell invasion through downregulating Sp1 in experimental glioblastoma.Cell Signal.2023.103.110581.SCI
5. Su X, Xie Y, Zhang J, Li M, Zhang Q, Jin G, Liu F*.HIF-alpha activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis.Cell Death Dis.2022.13(1).861.SCI
6. Zhang Q, Zhang J, Wang P, Zhu G, Jin G, Liu F *.Glioma-associated mesenchymal stem cells-mediated PD-L1 expression is attenuated by Ad5-Ki67/IL-15 in GBM treatment.Stem cell research & therapy.2022.13(1).284.SCI
7. Guidong Zhu, Junwen Zhang, Qing Zhang, Guishan Jin, Xiaodong Su, Sisi Liu, Fusheng Liu*.Enhancement of CD70?specific CAR T treatment by IFN?γ released from oHSV?1?infected glioblastoma.Cancer Immunology, Immunotherapy.2022.71(10).2433-2448.SCI
8. Ruifang Mi, Jiayu Ji, Mengmeng Zhang, Junwen Zhang, Mingxin Li, Yuedong Hu, Fusheng Liu*.Establishment of the glioma polyploid giant cancer cell model by a modified PHA-DMSO-PEG fusion method following dual drug-fluorescence screening in vitro.Journal of Neuroscience Methods.2022.368.109462.SCI
9. Xiangming Han, Qiyan Wang, Sheng Fang, Jialin Wang, Fusheng Liu, Junwen Zhang* and Guishan Jin*.P4HA1 regulates CD31 via COL6A1 in the transition of glioblastoma stem-like cells to tumor endothelioid cells.Frontiers in Oncology.2022.12.836511.SCI
10. Sisi Liu, Junwen Zhang, Sheng Fang, Qing Zhang, Guidong Zhu, Yifu Tian, Mingwei Zhao*, Fusheng Liu*.Macrophage polarization contributes to the efficacy of an oncolytic HSV-1 targeting human uveal melanoma in a murine xenograft model.Experimental EyeResearch.2021.202.108285.SCI
11. Chengyuan Dong, Sheng Hong, Diwei Zheng, Qianxiao Huang, Fusheng Liu*, Zhenlin Zhong*, Xianzheng Zhang*.Multifunctionalized Gold Sub-Nanometer Particles for Sensitizing Radiotherapy against Glioblastoma.Small.2021.17.e2006582.SCI
12. Zhu G, Zhang Q, Zhang J, Liu F*.Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment.Front Pharmacol.2021.12.661606.SCI
13. Wang Q, Zhang J, Fang S, Wang J, Han X, Liu F*, Jin G*.P4HA1 Down-Regulation Inhibits Glioma Invasiveness by Promoting M1 Microglia Polarization.Onco Targets Ther.2021.14.1771-1782.SCI
14. 季佳宇，王启俨，方胜，田毅夫，刘福生，米蕊芳*.EA-IL-15溶瘤腺病毒的构建及其对胶质瘤细胞特异性及有效性研究.医学研究杂志.2020.49（10）.47-51.核心期刊
15. 张梦梦，张俊文，米蕊芳，金贵善，刘福生*.siRNA干扰BTN3A3对脑胶质瘤细胞凋亡作用的研究.中华神经外科杂志.2020.36（9）.951-956.核心期刊
16. 方胜, 张俊文, 董程远, 田毅夫, 王启俨, 刘福生, 金贵善*.P4HA1调控EMT影响脑胶质瘤侵袭性研究.中国科学: 生命科学.2020.50（4）.446-457.核心期刊
17. Qing Zhang, Junwen Zhang, Yifu Tian, Guidong Zhu, Sisi Liu and Fusheng Liu*.Efficacy of a novel double-controlled oncolytic adenovirus driven by the Ki67 core promoter and armed with IL-15 against glioblastoma cell.Cell Bioscience.2020.10.124（1-12）.SCI
18. Shiqi Hu#, Chengyuan Dong#, Jinqiang Wang, Kexin Liu, Quan Zhou, Jiajia Xiang, Zhuxian Zhoua*, Fusheng Liu*, Youqing Shen*.Assemblies of indocyanine green and chemotherapeutic drug to cure established tumors by synergistic chemo-photo therapy.Journal of Controlled Release.2020.324.250-259.SCI
19. Sisi Liu, Junwen Zhang, Sheng Fang, Xiaodong Su, Qing Zhang, Guidong Zhu, Li Zhu, Mingwei Zhao*, Fusheng Liu*.Antitumor efficacy of oncolytic HSV-1 expressing cytosine deaminase is synergistically enhanced by DPD down-regulation and EMT inhibition in uveal melanoma xenograft.Cancer Letters.2020.495.123-134.SCI
20. Qing Zhang and Fusheng Liu*.Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas.Cell Death & Disease.2020.11:485.1-11.SCI
21. Junwen Zhang#, Sheng Fang#, Wenjie Song, Bo Zhang, Wenhua Fan, Guishan Jin, Fusheng Liu*.Biological Characterization and Therapeutics for Subscalp Recurrent in Intracranial Glioblastoma.OncoTargets and Therapy.2020.13.9085-9099.SCI
22. Ruifang Mi, Wenhua Fan, Jiayu Ji, Chengyuan Dong, Guishan Jin, Fusheng Liu*.The enhanced efficacy of herpes simplex virus by lentivirus mediated VP22 and cytosine deaminase gene therapy against glioma.Brain Research.2020.1743.146898（1-9）.SCI
23. Sisi Liu, Fusheng Liu, Mingwei Zhao, Junwen Zhang*.Antitumor efficacy of Oncolytic herpes virus type I armed with GM-CSF in murine uveal melanoma xenografts.Cancer Management and Research.2020.12.1-10.SCI
24. 张梦梦，苏晓东，田毅夫，季佳宇，刘福生*.BTN3A3低表达促进肝细胞癌的恶性进展.医学研究杂志.2020.49（4）.75-80.核心期刊
25. Yiqiang Zhou, Yang Liu, Junwen Zhang, Di Yu, Aiguo Li, Hua Song, Wei Zhang, Dionne Davis, Mark R. Gilbert, Fusheng Liu*, and Chunzhang Yang*.Autocrine BMP4 Signaling Enhances Tumor Aggressiveness via Promoting Wnt/β-Catenin Signaling in IDH1-mutant Gliomas.Translational Oncology.2020.13（2）.125-134.SCI
26. Quan Zhou, Chengyuan Dong, Wufa Fan, Haiping Jiang, Jiajia Xiang, Nasha Qiu,Ying Piao, Tao Xie, Yingwu Luo, Zichen Li, Fusheng Liu, Youqing Shen?.Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy.Biomaterials.2020.240.119902.SCI
27. Fan-Wei Meng, Fu-Sheng Liu, Wen-Hui Liu, Li Li and Lin-Lin Jie.Formation of new lymphatic vessels in glioma: An immunohistochemical analysis.Neuropathology.2020.40(3）.215-223.SCI
28. Chengyuan Dong, Junwen Zhang, Sheng Fang and Fusheng Liu*.IGFBP5 increases cell invasion and inhibits cell proliferation by EMT and Akt signaling pathway in Glioblastoma multiforme cells.Cell Division.2020.15.4.SCI
29. Chengyuan Dong, Quan Zhou, Jiajia Xiang*, Fusheng Liu*, Zhuxian Zhou*, Youqing Shen.Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy.Journal of Controlled Release.2020.321.529-539.SCI
30. 张俊文，范文华，方胜，陈虹，黄秉仁，刘福生*.shRNA干扰eIF4A1基因对胶质瘤细胞体内外生物学特征的影响.中国科学: 生命科学.2019.49.987-995.核心期刊
31. 张俊文，赵乔佳杰，杨霞，马雯，黄秉仁，刘福生*.RanBPM调控IFNlR1-STAT5通路分子机制研究.医学研究杂志.2019.48（8）.31-36.核心期刊
32. Bo Zhang#, Junwen Zhang#, Sheng Fang, Mengmeng Zhang, Sisi Liu, Yifu Tian, Mengjiao Ma, Fusheng Liu, Guishan Jin*. Inflammatory activation of microglia by Staphylococcus aureus caused phenotypic alterations and affected glioblastoma growth.Cell Biochem Funct.2019.1-9.DOI: 10.1002/cbf.3396.SCI
33. Zhang J, Cui B, Chen H, Huang BR*, Liu F*.eIF4A1 is associated with TrkA and inhibits TrkA polyubiquitination.Prog. Biochem, Biophys.2019.46（8）.812-822.SCI
34. Wenhua Fan, Meiyu Shao, Junwen Zhang, Guishan Jin, Fu-Jian Xu,* and Fusheng Liu*.Hybrid nanovector of suicide gene engineered lentivirus coated with bioreducible polyaminoglycosides for enhancing therapeutic efficacy against glioma.Adv. Funct. Mater..2019.29.1807104.SCI
35. 刘福生，李小鹏，田超，张俊文.TSPO在治疗脑胶质瘤中的应用及重组单纯疱疹病毒及其制备方法和应用。国家发明专利，专利号：ZL 2017 1 1251406.7.中华人民共和国国家知识产权局.2019. . .
36. 张俊文，刘福生，方胜，宋文杰.一种人脑胶质瘤细胞系及其建立方法和应用.国家发明专利，专利号：ZL 2018 1 1535397.9.中华人民共和国国家知识产权局.2019. . .
37. 张昀昇，张俊文，米蕊芳，周益强，程森，宋文杰，刘福生，金贵善*.TRIM33对人脑胶质瘤U251细胞生物学功能影响的实验研究.中华神经外科杂志.2018.34（3）.292-298.核心期刊
38. Sisi Liu #, Wenjie Song #, Fusheng Liu2, Junwen Zhang2*, Siquan Zhu1*.Antitumor efficacy of VP22-CD/5-FC suicide gene system mediated by lentivirus in a murine uveal melanoma model.Experimental Eye Research.2018.172.144-151.SCI
39. Yunsheng Zhang#, Guishan Jin#, Junwen Zhang, Ruifang Mi, Yiqiang Zhou, Wenhua Fan, Sen Cheng, Wenjie Song, Bo Zhang, Mengjiao Ma, Fusheng Liu*.Overexpression of STAT1 suppresses angiogenesis under hypoxia by regulating VEGF?A in human glioma cells.Biomedicine & Pharmacotherapy.2018.104.566-575.SCI
40. 徐恒周，金贵善，米蕊芳，张俊文，周益强，刘福生*.FASN在脑胶质瘤组织中的表达及其临床意义.中华神经医学杂志.2017.16（3）.217-221.核心期刊
41. Liu J, Wang Y, Sun X, Ji N, Sun S, Wang Y, Liu F, Cui Q, Wang C#, Liu Y#.Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.Oncology reports.2017.37.887-894.SCI
42. JW Zhang XJ Cong, J Zhao, X Yang, M Li, H Chen, FS Liu, *, BR Huang*.Ran bingding protein 9(RanBPM)binds IFN-λR1 in the IFN-λ signaling pathway.Sci China Life Sci.2017.60（9）.1030-1039.SCI
43. Zhou Y, Jin G, Mi R, Zhang J, Zhang J, Xu H, Cheng S, Zhang Y, Song W, Liu F*.Knockdown of P4HA1 inhibits neovascularization via targeting glioma stem cell-endothelial cell transdifferentiation and disrupting vascular basement membrane.Oncotarget.2017.8（22）.35877-35889.SCI
44. Sen Cheng#,Ruifang Mi #, Yu Xu,Guishan Jin,Junwen Zhang, Yiqiang Zhou,Zhengguang Chen, Fusheng Liu*.Ferritin heavy chain as a molecular imaging reporter gene in glioma xenografts.J Cancer Res Clin Oncol .2017.143（6）.941-951.SCI
45. 张俊文，丛晓杰，赵乔佳杰，杨霞，李梦，陈虹，米蕊芳，金贵善，黄秉仁，刘福生*.RanBPM结合干扰素γ信号通路中的干扰素受体1.中国科学 生命科学.2017.47（7）.718-727.核心期刊
46. Guobin Zhang, Yunsheng Zhang, Sen Cheng, Zhen Wu, Fusheng Liu*, Junting Zhang*.CD133 positive U87 glioblastoma cells-derived exosomal microRNAs in hypoxia- versus normoxia-microenviroment.J Neuro-oncol.2017.135.37-46.SCI
47. 张俊文,杜延顺,米蕊芳,陈虹,刘福生*,黄秉仁*.TGF-βRI与Fascin1的相互作用..基础医学与临床.2016.36（3）.315-319.核心期刊
48. 刘福生，金贵善*.对医学专业学位硕士研究生科研能力培养的思考与体会.医学教育管理.2016.2（2）.438-440.核心期刊
49. 米蕊芳，金贵善，张俊文，周益强，徐恒周，程森，刘福生*.VP22-CD基因工程化载体对胶质瘤细胞体外杀伤作用的研究.中华神经外科杂志.2016.6（32）.614-618.核心期刊
50. Mi RF, Pan CX, Zhou YQ, Liu YB, Jin GS*, Liu FS*.Identification of the metastasis potential and its associated genes in melanoma multinucleated giant cells using the PHA-ECM830 fusion method.Oncology reports.2016.35（1）.211-218.SCI
51. Zhou Y, Jin G, Mi R, Zhang J, Zhang J, Xu H, Cheng S, Zhang Y, Song W, Liu F*.Inhibition of fatty acid synthase suppresses neovascularization via regulating the expression of VEGF-A in glioma.J Cancer Res Clin Oncol.2016.142.2447-2459.SCI
52. 张俊文，刘福生*.医学基础学科研究生科学实验与研究能力培养方式探讨.医学教育管理.2016.2（supp2）.121-123.核心期刊
53. 金贵善，刘福生*.医学硕士研究生创新能力培养的分析和思考.医学教育管理.2016.2（supp2）.118-120.核心期刊
54. Yang Hu#, Yiqiang Zhou#, Nana Zhao, Fusheng Liu*, and Fu-jiang Xu*.Multifunctional pDNA-conjugated polycationic au nanorod-coated Fe3O4 hierarchical nanocomposites for trimodal imaging and combined photothermal/gene therapy.Small.2016.12(18).2459-2468.SCI
55. Nana Zhao, Jia Li, Yiqiang Zhou, Yang Hu, Ranran Wang, Zhaoxia Ji, Fusheng Liu*, Fujian Xu*. Hierarchical Nanohybrids of Gold Nanorods and PGMA-Based Polycations for Multifunctional Theranostics.Advanced functional materials.2016.26.5848-5861.SCI
56. 张国滨，张晋，徐恒周，周益强，程森，刘福生*.支链氨基酸氨基转移酶1在恶性胶质瘤中的表达及意义.中华神经外科杂志.2015.31（12）.1259-1262.核心期刊
57. 张晋，金贵善，米蕊芳，周益强，房绍伟，朱树干，刘福生*.脑胶质瘤干细胞内皮细胞分化差异基因表达谱的分析.中华神经外科杂志.2015.31（3）.299-303.核心期刊
58. Dong C#, Mi R#, Jin G, Zhou Y, Zhang J, Liu F*.Identification of the proliferative effect of Smad2 and Smad3 in TGFβ2/Smads signal pathway using RNA interference in glioma cell line.Molecular Medicine Reports.2015.12.1824-1828.SCI
59. Zhao Y, Duan S, Yu B, Liu FS, Cheng G, Xu FJ*.Gd(III) ino-chelated supramolecular assemblies composed of PGMA-based polycations for effective biomedical applications.NPG Asia Materials.2015.7.e197.SCI
60. Zhang GB, Jin GS, Nie XT, Mi RF, Zhu Guidong, Liu FS*.Enhanced antitumor efficacy of an oncolytic herpes simplex virus expressing an endostatin-angiostatin fusion gene in human glioblastomas stem cell xenografts.PLOS ONE.2014.9（4）.e95872.SCI
61. Zhou YQ, Jin GS, Mi RF, Dong CY, Zhang J, Liu FS*.The methylation status of the platelet-derived growth factor-B gene promoter and its regulation of cellular proliferation following folate treatment in human glioma cells.Brain Research.2014.1556.57-66.SCI
62. Yang Hu, Nana Zhao, Bingran Yu, Fusheng Liu*, Fu-Jian Xu*.Versatile types of Polysaccharide-Based Supramolecular Polycation/pDNA Nanoplexes for Gene Delivery.Nanoscale.2014.6（13）.7560-7569.SCI
63. 周益强， 金贵善，刘福生*.PDGF-B在脑胶质瘤中的研究进展.中华神经外科杂志.2014.30（8）.844-846.核心期刊
64. 张国滨，金贵善，米蕊芳，周益强，董程远，刘福生*.内皮抑素和血管生成抑素融合基因修饰的单纯疱疹病毒对胶质瘤干细胞杀伤作用的实验研究.中华神经外科杂志 .2014.30（7）.723-728.核心期刊
65. Bin Xu, Dong-Ming Yu*, Fu-Sheng Liu*.Effect of siRNA?induced inhibition of IL?6 expression in rat cerebral gliocytes on cerebral edema following traumatic brain injury.Molecular Medicine Reports.2014.10.1863-1864.SCI
66. 董程远，金贵善，米蕊芳，周益强，张晋，刘福生*.shRNA干扰技术对脑胶质瘤细胞中TGFβ2/Smads通路的研究.中华神经外科杂志.2014.30（4）.404-408.核心期刊
67. 聂秀涛，金贵善，徐厚池，刘福生*.脑胶质瘤干细胞和血管关系的研究进展.中华神经外科杂志.2014.30(3).315-317.核心期刊
68. 陈宝师，毕智勇，张忠，刘福生*.靶向联合化疗治疗原发性中枢神经系统淋巴瘤的研究.中华神经医学杂志.2014.13（1）.83-85.核心期刊
69. 周益强，金贵善 米蕊芳 董程远 张晋 刘福生*.血小板源性生长因子B及其基因启动子区甲基化在脑胶质瘤中的表达及意义.中华神经外科杂志.2014.30(3).288-291.核心期刊
70. Peng Yan, Nana Zhao, Hao Hu, Xinyi Lin, Fusheng Liu, Fujian Xu*.A facile strategy to functionalize gold nanorods with polycation brushes for biomedical applications.Acta Biomater.2014.10（8）.3786-3794.SCI
71. 刘福生.努力提高脑胶质瘤的诊治水平.中华临床医师杂志.2013.7（14）.6217-6219.核心期刊
72. 聂秀涛，金贵善，米蕊芳，张国滨，谢坚，曹泽，周益强，董程远，刘福生*.人脑胶质瘤干细胞分化为血管内皮细胞的实验研究.中华神经外科杂志.2013.29（3）.289-293.核心期刊
73. 米蕊芳，刘福生，金贵善*.多核巨细胞对小鼠黑色素瘤细胞转移能力的研究.中华临床医师杂志.2013.7(14).6457-6461.EI
74. Jin GS, Hao SY, Xie J, Mi RF and Liu FS*.Collision tumors of the sella: coexistence of pituitary adenoma and craniopharyngioma in the sellar region.World journal of surgical Oncology.2013.11.178（1-7）.SCI
75. 董程远，米蕊芳，刘福生*.TGF-beta/Smads 通路中信号转导蛋白Smad2与Smad3的差异性研究进展.中华临床医师杂志.2013.7（14）.6579-6581.核心期刊
76. 米蕊芳，刘福生，金贵善*.植物血凝素-ECM830细胞融合法融合黑色素瘤细胞.中国医学科学院学报.2013.35（5）.515-518.核心期刊
77. Jin GS, Zhou YQ, Chai Q, Zhu GD, Xu FJ, Liu FS*.VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy.journal of cancer research and clinical oncology.2013.139.475-483.SCI
78. 曹泽，金贵善，刘福生*，谢坚.TGF-β2/Smad2 在人脑胶质瘤组织中的表达及意义.中华临床医师杂志.2012.6（6）.43-46.核心期刊
79. 金贵善，刘福生*.培养科研型硕士研究生的科研思维.首都医科大学学报社科版.2012.增刊.353-354.核心期刊
80. 刘福生，金贵善*.指导临床医学科研型硕士研究生发表SCI论文.首都医科大学学报社科版.2012.增刊.355-357.核心期刊
81. Jin GS, Zhu GD, Zhao ZG, Liu FS* .VP22 enhances the expression of gluco-cerebrosidase in human Gauche II fibroblast cells mediated by lentivirus vector.Clinical and experimental medicine.2012.12.135-143.SCI
82. 谢坚，李春德，刘福生*，陆睁，郭而安，张鹏飞，梁雄立，廖浩.经脑外侧裂切除岛叶胶质瘤.中华神经外科杂志.2011.27（2）.208-209.核心期刊
83. 苏伟，朱贵东，刘福生*，姜中利，金贵善，柴奇，曹泽，聂秀涛.Smad2基因在人脑胶质瘤的表达及其临床意义.中华神经外科杂志.2011.27（10）.1064-1068.核心期刊
84. 张国滨，刘福生*、王忠诚.脑胶质瘤干细胞巢的研究进展.中华神经外科杂志.2011.27（12）.1287-1290.核心期刊
85. 苏伟，刘福生*，朱贵东，姜中利，金贵善，柴奇，曹泽.人脑胶质瘤中转化生长因子β2、Smad3蛋白表达及临床意义.中国康复理论与实践.2011.17（5）.433-436.核心期刊
86. 朱贵东，刘福生*，苏伟，金贵善，柴奇.内皮抑素和血管生成抑素融合基因修饰的单纯疱疹病毒对胶质瘤干细胞的体外实验研究.中华神经外科杂志.2011.27（9）.949-954.核心期刊
87. 苏伟，刘福生*，姜中利.TGF-β/smads信号通路与胶质瘤研究进展.中华神经外科杂志.2011.27（3）.322-324.核心期刊
88. Xu FJ, Zhu Y, Chai MY，Liu FS*.Comparison of ethanolamine/ethylenediamine-functionalized poly (glycidyl methacrylate) for efficient gene delivery.Acta Biomaterialia.2011.7.3131-3140.SCI
89. Zhu GD, Su W，Jin GS, Xu FJ, Hao SY, Guan FX, Jia W, Liu FS*.Glioma stem cells targeted by oncolytic virus carrying endostatin-angiostatin fusion gene and the expression of its exogenous gene in vitro.Brain Research.2011.1390.59-69.SCI
90. 朱贵东，刘福生*.溶瘤病毒治疗脑胶质瘤新进展.中华神经外科杂志.2010.26（5）.472-474.核心期刊
91. Xu FJ, Zhu Y, Liu FS，Nie J, Ma J, Yang WT.Comb-shaped conjugates comprising hydroxypropyl cellulose and low-molecular-weight poly (N-isopropylacryamide) side chains for smart hydrogeis: sythesis, characterization and biomedical applications..Bioconjugate Chemistry.2010.21(3).456-464.SCI
92. Xu FJ, Chai MY, Li WB, Ping Y, Tang GP, Yang WT, Ma J, Liu FS*.Well-defined poly (2-hydroxyl-3-(2-hydroxyethlamino) propyl methacylate) vectors with low cytotoxicity and high gene transfection efficiency.Biomacromolecules.2010.11(6).1437-1442.SCI
93. 金贵善, 刘福生* ,柴奇, 苏伟 ,朱贵东.VP22修饰的CD基因工程化干细胞治疗大鼠C6胶质瘤体外胶质瘤的研究.中华神经外科杂志.2009.25(11).1039-1043.核心期刊
94. 金贵善，刘福生*，柴奇，苏伟，朱贵东.慢病毒载体VP22-EGFP的构建及其对大鼠神经干细胞转染及表达的研究.中华神经外科杂志.2009.25.278-282.核心期刊
95. 王建交，李青松，詹奇，郑永日，刘福生*.大鼠C6胶质瘤模型构建及生长特性的研究.中国康复理论与实践.2009.15（8）.742-744.核心期刊
96. 李远，焦红亮，官方霞，宋来君，杨波，胡祥，杜英，李惠翔，庞霞，刘福生*，薛敬礼.人羊膜间充质干细胞移植对荷瘤鼠C6胶质瘤生长的抑制.中国组织工程研究与临床康复.2008.12（51）.10099-10103.核心期刊
97. 王建交，杨立庄，刘福生* ，金贵善，柴奇.内皮抑素和血管生成抑素融合基因的裂解病毒对C6胶质瘤的实验研究.中华神经外科杂志.2008.24（1）.69-72.核心期刊
98. Zhang Z, Jiang T, Xie J, Liu FS, Li SW, Qiao H, Wang ZC.Surgical strategies for glioma involving language areas..Chinese Medical Journal.2008.121(18).1800-1805.SCI
99. Jin GS, Liu FS*, Chai Q, Wang JJ, Li JH..Stable EGFP gene expression in C6 glioma cell line after transduction with HIV-based lentiviral vector.Chinese Journal of Cancer Research.2008.20.243-248.SCI
100. 金贵善，刘福生*，柴奇，王建交，车树圣.慢病毒介导的稳定表达绿色荧光蛋白的C6胶质瘤细胞株的建立及其生物学特性的观察.中华神经外科杂志.2007.23.541-544.核心期刊
101. 车树圣，孟庆海，金澎，李洛，刘福生*.脑胶质瘤干细胞的体外培养与生物学特性的观察.山东医药.2007.47（15）.1-2.核心期刊
102. Jin GS, Liu FS*, Chai Q, Li JH.Fusions of dendritic cells transfected with TGF-β1 antisense in treatment of intracranial gliomas..Chinese Journal of Cancer Research.2007.19.113-118.SCI
103. 刘福生*，历俊华，林松，王忠诚.树突状细胞与反义TGF-β1基因修饰的胶质瘤细胞融合瘤苗治疗脑胶质瘤的实验研究.中华神经外科杂志.2006.22（1）.47-50.核心期刊
104. 姜中利，王忠诚，江涛，刘福生*.颞叶内侧低级别胶质瘤手术治疗效果分析.山东大学学报.2006.44（5）.481-483.核心期刊
105. 刘福生，王忠诚.神经干细胞治疗脑胶质瘤的研究进展.中华神经外科杂志.2005.22（2）.123-126.核心期刊
106. 张建，张庆林，王成伟，于贻飞，郭华，孔建新，陶荣杰，刘福生*.胶质瘤多药耐药细胞株大鼠动物模型的建立及其生物学性质.中国医学科学院学报.2004.26 （1）.43-46.核心期刊
107. Liu Yuguang, Zhang Liangwen, Liu Fusheng, Zhu Shugan, Li Xingang, Su Wandong, Wu Chengyuan.Chronic expanding intracerebral hematoma.Journal of Clinical Neuroscience.2003.10(6).680–682.SCI
108. 刘福生，历俊华，王忠诚.胶质瘤免疫治疗的新进展.国外医学免疫学分册.2003.26（1）.31-33.核心期刊
109. 刘福生，历俊华，王忠诚.树突状细胞细胞株的研究进展.国外医学免疫学分册.2002.25（5）.279-282.核心期刊
110. 刘福生，王忠诚，历俊华，林松，任铭，肖庆，张亚卓.肿瘤抗原致敏树突状细胞瘤苗治疗颅内胶质瘤的实验研究.中华神经外科杂志.2002.18（2）.91-95.核心期刊
111. Chen Jianli, Jiang Sen, Yang Ruifang, Liu Fusheng, Sun Xiaoming.Mechanism of drug resistance and reversal with ligustra-zine and cyclosporina in cisplatin-induced human epithelial ovarian cancer resistant cell line 3Ao/cDDP..Chinese Journal of Cancer Research.2002.12(3).197-203.SCI
112. Liu Fusheng*, Wang Zhongcheng, Zhang Qinglin, Li Junhua, Zhang Yazhuo.Establishment of multidrug-resistance cell line C6/adr and reversal of drug resistance.Chinese Medical Journal.2002.115(2).238-241.SCI
113. 刘福生，张亚卓.树突状细胞与肿瘤的免疫治疗策略.神经疾病与精神卫生.2001.1（1）.3-4.核心期刊
114. 刘福生，张庆林，赵丽，王成伟 ，金澎.胶质瘤多药耐药机制的研究.中华外科杂志.2001.39（2）.172.核心期刊
115. 刘福生，张庆林.影响脑胶质瘤化疗效果的主要因素.山东医药.2001.41（7）.52-53.核心期刊
116. 刘福生，张庆林，卞继峰，庞琦，王成伟.胶质瘤多药耐药细胞系C6/adr的建立及其生物学特性的研究.中华神经外科杂志.2001.17（2）.109-112.核心期刊
117. 刘福生，张庆林，赵丽，王成伟，金澎.脑胶质瘤多药耐药细胞系C6/adr的建立及其耐药性逆转的研究.中华神经外科杂志.2000.16（5）.320-323.核心期刊
118. 刘福生，张庆林，刘玉光，徐淑军.慢性扩张性脑内血肿11例报告.山东医科大学学报.1999.37（2）.156-157.核心期刊
119. 刘福生，张庆林，刘玉光，徐淑军.慢性扩张性脑内血肿.中华误诊学杂志.1998.1.48-49.核心期刊
120. 刘福生，魏东光，张庆林.HSV-tk /GCV系统基因治疗颅内恶性胶质瘤的新进展.中国肿瘤临床与康复.1998.5（5）.83-84.核心期刊
121. 刘福生，刘百波，丁晓东.颅脑损伤后你慢性脑肿胀18例分析.潍坊医学院学报.1996.18（3）. .核心期刊
122. 刘福生，张成，刘玉光，杨琳，张庆林.鼠脑内注射rIL-2对脑组织和血脑屏障的影响.潍坊医学院学报.1995.17（3）.169-171.核心期刊
123. 刘福生，张文东，王在震，刘玉光.过继性免疫治疗颅内转移瘤1例.山东医药.1994.34（11）.62.核心期刊
124. 张文东，刘福生*.IL-2/LAK细胞疗法在神经外科的应用.山东医药.1994.34（7）.45.核心期刊
125. 杨廷舰，王成伟，匡绍华，刘福生*.凹陷性骨折至窦汇损伤成功止血1例.潍坊医学院学报.1994.10（4）.266.核心期刊
126. 刘福生，王成伟，匡绍华，杨廷舰，唐卫华.侧脑室内神经节神经瘤1例.潍坊医学院学报.1994.16（4）.262.核心期刊
127. 刘福生，刘玉光.三维CT血管造影诊断脑血管疾病（译文）.国外医学神经病学神经外科学分册.1992.5.279.核心期刊
128. 刘福生，刘玉光.脑室引流与动脉瘤再出血的关系（译文）.国外医学神经病学神经外科学分册.1992.5.280.核心期刊
主编或副主编的著作/译著
1. 《脑胶质瘤基础与临床研究》,主编,人民卫生出版社,201603
2. 《脑胶质瘤》,主编,人民卫生出版社,200704
重要奖项
1. 脑胶质瘤化学治疗和生物治疗的研究 山东省科学技术进步奖 二等奖 201312
2. 脑胶质瘤化学治疗和生物治疗的实验研究 华夏医学科技奖 二等奖 201208
3. 脑胶质瘤化学治疗和生物学治疗的实验研究 山东高等学校优秀科研成果奖 一等奖 201112
4. 脑胶质瘤生物学特性及阻断胶质瘤耐药基因的研究 中华医学科技奖 三等奖 200712
5. 反义寡核苷酸阻断脑胶质瘤耐药基因表达的实验研究 山东省科学技术奖（自然科学奖） 三等奖 200704
6. 脑胶质瘤生物学特性的实验研究 教育部提名的国家科技进步奖 二等奖 200301
7. 脑胶质瘤生物学特性的研究 山东省科学技术奖（科技进步奖） 一等奖 200209
8. 特殊类型颅内血肿的诊断与治疗 山东省科学技术奖（科技进步奖） 三等奖 200209
9. 山东省十大科技成果奖 山东省十大科技成果奖 2002
10. 山东省优秀博士毕业生 山东省优秀博士毕业生 2000
